Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
15 hedge funds and large institutions have $10.3M invested in Yield10 Bioscience, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
12% more capital invested
Capital invested by funds: $9.2M → $10.3M (+$1.09M)
7% more funds holding
Funds holding: 14 → 15 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$1.65M |
| 2 |
FA
FCG Advisors
Chatham,
New Jersey
|
+$137K |
| 3 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
+$34.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Aperio Group
Sausalito,
California
|
-$76K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$34.3K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.3K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21K |
| 5 |
GA
Geneva Advisors
Chicago,
Illinois
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WEC
26
Winslow Evans & Crocker
Boston,
Massachusetts
| $84 | – | – | – |
|
|
AG
27
Aperio Group
Sausalito,
California
| – | -$76K | -1 | Closed |
|
28
Citadel Advisors
Miami,
Florida
| – | -$11K | – | – |
|
29
Citigroup
New York
| – | -$1K | – | – |
|
|
GA
30
Geneva Advisors
Chicago,
Illinois
| – | -$18K | – | – |
|
|
31
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$21K | – | – |
|
YTEN Hedge Fund Activity: Q4 2014 in Review
15 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2014, worth a combined $10.3M — up 12% from $9.2M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new YTEN positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Oracle Investment Management, adding an estimated $1.65M. The largest seller was Aperio Group, exiting entirely with an estimated $76K sold.
- 15 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2014, up from 14 in Q3 2014.
- Funds reported $10.3M of Yield10 Bioscience, Inc. Common Stock stock for Q4 2014, up 12% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2014 and 1 closed out, a net change of +1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2014 was Oracle Investment Management, an estimated $1.65M added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2014 was Aperio Group, an estimated $76K sold.
Based on aggregated 13F filings for Q4 2014.